Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,194 | -124,021 | -77,111 | -45,101 | -16,829 |
| Depreciation Amortization | 555 | 1,990 | 1,502 | 1,041 | 558 |
| Accounts receivable | -2,548 | -2,619 | 170 | 1,363 | 371 |
| Accounts payable and accrued liabilities | 1,533 | 2,994 | 3,732 | 2,711 | -353 |
| Other Working Capital | -4,649 | 10,382 | 4,750 | 4,134 | -3,282 |
| Other Operating Activity | 2,985 | 11,430 | 6,763 | 4,440 | 2,956 |
| Operating Cash Flow | $-42,318 | $-99,844 | $-60,194 | $-31,412 | $-16,579 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -1,159 | -2,012 | N/A | N/A |
| PPE Investments | -1,692 | -3,369 | -1,495 | -533 | -6 |
| Other Investing Activity | 0 | 0 | 0 | -2,012 | 0 |
| Investing Cash Flow | $-1,692 | $-4,528 | $-3,507 | $-2,545 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,205 | 237,940 | 170,986 | 76,125 | 62,230 |
| Common Stock Repurchased | N/A | -13,760 | -5,949 | -5,949 | -3,047 |
| Other Financing Activity | 0 | -9,650 | -9,650 | -9,650 | -9,650 |
| Financing Cash Flow | $20,205 | $214,530 | $155,387 | $60,526 | $49,533 |
| Exchange Rate Effect | 6 | -31 | -17 | -13 | -9 |
| Beginning Cash Position | 209,807 | 99,680 | 99,680 | 99,680 | 99,680 |
| End Cash Position | 186,008 | 209,807 | 191,349 | 126,236 | 132,619 |
| Net Cash Flow | $-23,799 | $110,127 | $91,669 | $26,556 | $32,939 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,318 | -99,844 | -60,194 | -31,412 | -16,579 |
| Capital Expenditure | -1,692 | -3,369 | -1,495 | -533 | -6 |
| Free Cash Flow | -44,010 | -103,213 | -61,689 | -31,945 | -16,585 |